All In Biotech

Drug Trial Radar · NCT04442347

Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency

A Phase 1b Randomized, Double Blinded, Placebo Controlled, Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single Doses of ARCT-810 in Clinically Stable Patients With Ornithine Transcarbamylase Deficiency

Last checked: Nov 19, 2026Latest source record: Aug 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

16

Actual

Start

Nov 3, 2020

Primary completion

Aug 30, 2023

Study completion Apr 30, 2024

Sponsor

Lead sponsor
Arcturus Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jun 22, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Determine the safety, tolerability and pharmacokinetics of single doses of ARCT-810 in clinically stable patients (stable on standard of care treatment, e.g. diet ± ammonia scavengers) with ornithine transcarbamylase deficiency (OTCD).

Conditions

  • Ornithine Transcarbamylase Deficiency

Interventions

  • ARCT-810Biological

    ARCT-810 is an investigational medicinal product comprising Ornithine Transcarbamylase (OTC) mRNA formulated in a lipid nanoparticle (LNP) under development.

  • PlaceboOther

    The placebo for this study is 0.9% sterile saline.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence, severity and dose-relationship of adverse events (AEs)Time frame: 4 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • University of Florida

    Gainesville, Florida

  • M Health Fairview Masonic Children's Hospital

    Minneapolis, Minnesota

  • The Mount Sinai Hospital

    New York, New York

  • Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas

  • Baylor University

    Waco, Texas

  • University of Utah

    Salt Lake City, Utah

  • Children's Wisconsin - Milwaukee Hospital

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.